Please assess the completion status of the following clinical trial:

Trial Title: The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* type 2 diabetes who used Suglat Tablets within 3 months from its launch~Exclusion Criteria:~* off-label use patients

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Suglat group (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).